Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
ASGCT has partnered with NORD to offer a two-part virtual CME program, The Time Is Now: Understanding Gene Therapy, Applications, and Implications, to educate clinicians on gene therapy.
ASGCT members and those in the gene therapy community pursuing CME credits will be excited to learn about the Society's latest partnership with the National Organization for Rare Disorders (NORD), The Time Is Now: Understanding Gene Therapy, Applications, and Implications. This two-part series begins on Thursday, April 22 at 2 p.m. ET, and will reconvene on Thursday, April 29 for part two.
Register for This CME Event
This CME-providing program is designe for a clinical audience to:
Gene Transfer, Editing, Silencing and RNA Based‐Approaches: What, When and How?
Clinical Development and Regulatory Oversight of Gene-Based Therapies From Development to Post-Marketing
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico